FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Atropine Sulfate Injection
Status: Discontinuation
»Therapeutic Categories: Anesthesia; Neurology; Pediatric

Expand all

Hospira, Inc., a Pfizer Company (New 11/07/2025)

Company Contact Information:
844-646-4398

Presentation	Posting Date	Related Information
Atropine Sulfate, Injection, (Adult) 0.5 mg/5 mL (0.1 mg/mL) LifeShield® ABBOJECT® Glass Syringe (20 G x 1 1/2") (NDC 0409-4910-34)	11/07/2025	Discontinuation of the manufacture of the drug
Atropine Sulfate, Injection, (Adult)1 mg/10 mL (0.1 mg/mL) LifeShield® ABBOJECT® Glass Syringe (20 G x 1 1/2") (NDC 0409-4911-34)	11/07/2025	Discontinuation of the manufacture of the drug